Standing at the "tuyere" of biopharmaceutical market 2018 Shanghai bio fermentation exhibition will set off a new wave of pharmaceutical innovation

[China Pharmaceutical network exhibition report] in recent years, under the background of high-frequency policy guidance, healthy China's industrial development strategy promotion and the trend of aging population, China's pharmaceutical industry is gradually ushering in a new development cycle As a strategic emerging industry, biopharmaceutical industry has the characteristics of high technology content, high added value, less energy consumption, knowledge intensive and so on Its market prospect is even broader According to some data, the sales volume of biopharmaceutical industry is growing at an average annual rate of 25% - 30%, becoming one of the fast-growing industries With a compound growth rate of 18.1%, biopharmaceuticals are becoming a market outlet with trillions of dollars of value Nowadays, biopharmaceutical industry is rapidly developing from high-tech industry with development potential to high-tech pillar industry, which has become an important part of manufacturing industry It is regarded as a sunrise industry, and is regarded as the gem of the new round of technological revolution, with a very rapid development momentum Some institutions predict that the compound growth rate of China's biopharmaceutical industry will reach 18.1% By 2020, China's biopharmaceutical industry is expected to form a market scale of 8 trillion yuan, which is becoming a market outlet with a value of several trillion dollars In China, biopharmaceuticals are ushering in a new era of development with the support of favorable policies and the promotion of advanced technology In recent years, China has attached great importance to the innovation and development of biopharmaceutical industry Many of the policy documents issued in this regard have provided overall, forward-looking and fundamental guidance for the innovation and development of biopharmaceutical industry For example, "healthy China" has become a national strategy, and a grand banquet of 100 billion level industrial investment has been opened; made in China 2025 takes biopharmaceuticals as a key development area, and continues to accelerate the cultivation of strategic emerging industries such as biopharmaceuticals as the pillar industries of the national economy The implementation of these major policies has provided strong policy and financial support for the innovation and development of biopharmaceutical industry Driven by the favorable policies and market environment, China's biopharmaceutical industry has a huge development opportunity In the next decade, the pharmaceutical innovation industry will usher in great qualitative changes and become the main line of development However, opportunities and challenges coexist Biopharmaceutics is also an investment field with large investment, long cycle, slow effect and high risk How to improve production efficiency, reduce production costs and shorten the time to market of new products are all the aspects that enterprises focus on So in the face of huge market opportunities and challenges, how can enterprises follow the trend? The author has learned that the 6th Shanghai International bio fermentation products and Technology Equipment Exhibition (hereinafter referred to as "Shanghai bio fermentation Exhibition") hosted by China Bio Fermentation Industry Association and hosted by Shanghai Xinshi Exhibition Service Co., Ltd will be held in Shanghai New International Expo Center on September 4-6, 2018 At that time, people of insight will gather to develop the bio pharmaceutical industry Give directions Focusing on new products, new technologies and new processes of biopharmaceutical industry, Shanghai bio fermentation exhibition will usher in a new era of biopharmaceutical industry in the near future A step-by-step film "I am not the God of medicine" on medical theme has been released for 12 days, and the box office has exceeded 2.5 billion yuan! This makes the innovative research and development of medicine and biopharmaceutical industry attract attention from all walks of life I'm not the God of medicine The innovation and R & D of biopharmaceutical industry is the eternal theme of the development of pharmaceutical industry I've learned that Shanghai bio fermentation exhibition, as the annual "drama" that the global bio fermentation industry is waiting for, will gather new products, new technologies, new processes and new ideas of the bio pharmaceutical industry, which will surely bring innovation and development of the bio pharmaceutical industry New interpretation The scope of exhibits in this exhibition includes biological fermentation laboratory equipment, such as breeding equipment, cell fermentation tank, cell culture system, cell reactor, online detector, etc.; biological products, such as protein, polypeptide, antigen, antibody, vaccine, etc; Engineering and technical equipment, such as fermentation tank, control system, instrument, drying equipment, cooling equipment, heat exchange equipment, mixing equipment, etc With the strong support of the policy, 2018-2022 will be a good opportunity for the innovation and development of China's biological and pharmaceutical industry As an integral part of the pharmaceutical, biopharmaceutical, bioengineering, cell engineering and laboratory equipment industries, biological fermentation is bound to meet a huge development opportunity Based on the "tuyere" of biopharmaceutical industry development, Shanghai bio fermentation exhibition will set off a new wave for pharmaceutical innovation and development It is understood that the exhibition area of this Shanghai biological fermentation exhibition will reach 30000 square meters It is committed to building a platform for technical exchange, cooperation promotion, upstream and downstream trade expansion, brand and enterprise awareness for the biological fermentation industry and related medicine, and to building a comprehensive exhibition of the whole industrial chain of biological fermentation In this annual feast, the biomedical industry, bioengineering / cell and vaccine giants, and scientific research institutions will all be present For example, AstraZeneca, Harbin Pharmaceutical Group, Fosun Pharmaceutical, Qilu pharmaceutical, Xinhua Pharmaceutical, Roche, Shanghai Pharmaceutical Group, Yangzijiang pharmaceutical, geelide, Wuhan Huamei, Shanghai Huake biology, etc will gather at this exhibition The pharmaceutical industry is an important part of the national economy, and now our country is moving towards a strong pharmaceutical innovation country The made in China 2025 issued by our country lists biopharmaceuticals as one of the key areas to vigorously promote development in the next step, emphasizes the development of new target chemicals, antibody drugs, new vaccines, and is committed to breakthroughs in stem cells and other fields How to promote the innovation and development of medicine and biopharmaceutical industry has become a focus topic in China On September 4-6, the Shanghai bio fermentation exhibition held in Shanghai New International Expo Center was the annual feast of the bio fermentation industry, gathering a large number of heroes Pharmaceutical companies may find new ideas and new solutions here 2018 Shanghai bio fermentation exhibition, let's wait and see! Scan it, pre register it in advance and send it to Haoli